Medtronic plc (MDT)
USD 80.03
(-1.65%)
USD 80.03
(-1.65%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 5.14 Billion USD | -6.22% |
| 2023 | 5.48 Billion USD | -4.64% |
| 2022 | 5.75 Billion USD | 28.28% |
| 2021 | 4.48 Billion USD | -6.41% |
| 2020 | 4.79 Billion USD | -23.56% |
| 2019 | 6.26 Billion USD | -5.76% |
| 2018 | 6.65 Billion USD | 24.78% |
| 2017 | 5.33 Billion USD | 0.74% |
| 2016 | 5.29 Billion USD | 40.49% |
| 2015 | 3.76 Billion USD | -7.79% |
| 2014 | 4.08 Billion USD | -11.96% |
| 2013 | 4.63 Billion USD | -1.21% |
| 2012 | 4.69 Billion USD | 12.53% |
| 2011 | 4.17 Billion USD | -4.53% |
| 2010 | 4.37 Billion USD | 55.5% |
| 2009 | 2.81 Billion USD | -2.56% |
| 2008 | 2.88 Billion USD | -17.92% |
| 2007 | 3.51 Billion USD | 11.19% |
| 2006 | 3.16 Billion USD | 24.29% |
| 2005 | 2.54 Billion USD | -9.06% |
| 2004 | 2.79 Billion USD | 19.46% |
| 2003 | 2.34 Billion USD | 53.61% |
| 2002 | 1.52 Billion USD | -1.63% |
| 2001 | 1.54 Billion USD | -4.89% |
| 2000 | 1.62 Billion USD | 98.18% |
| 1999 | 822 Million USD | 17.09% |
| 1998 | 702 Million USD | -13.25% |
| 1997 | 809.2 Million USD | 21.07% |
| 1996 | 668.4 Million USD | 51.19% |
| 1995 | 442.1 Million USD | 27.48% |
| 1994 | 346.8 Million USD | 15.95% |
| 1993 | 299.1 Million USD | 23.14% |
| 1992 | 242.9 Million USD | 23.74% |
| 1991 | 196.3 Million USD | 22.76% |
| 1990 | 159.9 Million USD | 6.39% |
| 1989 | 150.3 Million USD | 14.65% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | 1.52 Billion USD | 2.97% |
| 2024 Q1 | 1.26 Billion USD | -18.98% |
| 2024 Q2 | 1.34 Billion USD | 5.68% |
| 2024 Q3 | 1.48 Billion USD | 10.67% |
| 2024 FY | 5.73 Billion USD | 4.5% |
| 2023 Q1 | 1.07 Billion USD | -37.41% |
| 2023 Q3 | 1.39 Billion USD | -0.85% |
| 2023 Q4 | 1.56 Billion USD | 12.43% |
| 2023 Q2 | 1.4 Billion USD | 31.09% |
| 2023 FY | 5.48 Billion USD | -4.64% |
| 2022 FY | 5.75 Billion USD | 28.28% |
| 2022 Q3 | 1.65 Billion USD | 6.14% |
| 2022 Q2 | 1.56 Billion USD | 81.96% |
| 2022 Q1 | 859 Million USD | -46.55% |
| 2022 Q4 | 1.71 Billion USD | 3.13% |
| 2021 FY | 4.48 Billion USD | -6.41% |
| 2021 Q2 | 930 Million USD | 38.19% |
| 2021 Q3 | 1.27 Billion USD | 37.31% |
| 2021 Q4 | 1.6 Billion USD | 25.84% |
| 2021 Q1 | 673 Million USD | 112.3% |
| 2020 Q2 | 1.35 Billion USD | -9.02% |
| 2020 Q3 | 1.63 Billion USD | 21.32% |
| 2020 Q1 | 1.48 Billion USD | -23.69% |
| 2020 FY | 4.79 Billion USD | -23.56% |
| 2020 Q4 | 317 Million USD | -80.66% |
| 2019 Q1 | 1.23 Billion USD | -36.12% |
| 2019 Q2 | 1.54 Billion USD | 24.92% |
| 2019 Q3 | 1.54 Billion USD | -0.13% |
| 2019 Q4 | 1.94 Billion USD | 26.2% |
| 2019 FY | 6.26 Billion USD | -5.76% |
| 2018 Q3 | 1.42 Billion USD | -24.99% |
| 2018 FY | 6.65 Billion USD | 24.78% |
| 2018 Q1 | 1.38 Billion USD | -14.84% |
| 2018 Q2 | 1.9 Billion USD | 36.86% |
| 2018 Q4 | 1.93 Billion USD | 35.69% |
| 2017 Q2 | 1.38 Billion USD | 18.68% |
| 2017 FY | 5.33 Billion USD | 0.74% |
| 2017 Q4 | 1.63 Billion USD | 42.2% |
| 2017 Q1 | 1.16 Billion USD | -22.51% |
| 2017 Q3 | 1.14 Billion USD | -17.18% |
| 2016 Q3 | 1.35 Billion USD | 4.23% |
| 2016 Q4 | 1.5 Billion USD | 11.14% |
| 2016 FY | 5.29 Billion USD | 40.49% |
| 2016 Q1 | 1.13 Billion USD | 203.22% |
| 2016 Q2 | 1.3 Billion USD | 14.94% |
| 2015 Q4 | 373 Million USD | -72.77% |
| 2015 FY | 3.76 Billion USD | -7.79% |
| 2015 Q2 | 1.11 Billion USD | -5.42% |
| 2015 Q1 | 1.18 Billion USD | 102.05% |
| 2015 Q3 | 1.37 Billion USD | 22.76% |
| 2014 FY | 4.08 Billion USD | -11.96% |
| 2014 Q1 | 1.24 Billion USD | -1.35% |
| 2014 Q3 | 1.04 Billion USD | -13.54% |
| 2014 Q2 | 1.21 Billion USD | -2.57% |
| 2014 Q4 | 584 Million USD | -44.22% |
| 2013 Q3 | 1.25 Billion USD | 32.03% |
| 2013 Q2 | 949 Million USD | -19.37% |
| 2013 Q1 | 1.17 Billion USD | -4.46% |
| 2013 FY | 4.63 Billion USD | -1.21% |
| 2013 Q4 | 1.26 Billion USD | 0.56% |
| 2012 FY | 4.69 Billion USD | 12.53% |
| 2012 Q4 | 1.23 Billion USD | 0.0% |
| 2012 Q3 | 1.23 Billion USD | 8.26% |
| 2012 Q2 | 1.13 Billion USD | 3.55% |
| 2012 Q1 | 1.09 Billion USD | 6.08% |
| 2011 Q4 | 1.03 Billion USD | -7.99% |
| 2011 FY | 4.17 Billion USD | -4.53% |
| 2011 Q2 | 865 Million USD | -24.59% |
| 2011 Q1 | 1.14 Billion USD | -14.53% |
| 2011 Q3 | 1.12 Billion USD | 30.17% |
| 2010 Q4 | 1.34 Billion USD | 15.69% |
| 2010 FY | 4.37 Billion USD | 55.5% |
| 2010 Q1 | 665 Million USD | 1285.42% |
| 2010 Q2 | 1.2 Billion USD | 80.9% |
| 2010 Q3 | 1.16 Billion USD | -3.57% |
| 2009 Q2 | 661 Million USD | -30.64% |
| 2009 Q1 | 953 Million USD | -5.08% |
| 2009 Q4 | 48 Million USD | -94.85% |
| 2009 Q3 | 932 Million USD | 41.0% |
| 2009 FY | 2.81 Billion USD | -2.56% |
| 2008 Q2 | 868 Million USD | -1.25% |
| 2008 Q4 | 1 Billion USD | 643.7% |
| 2008 FY | 2.88 Billion USD | -17.92% |
| 2008 Q1 | 879 Million USD | 2.81% |
| 2008 Q3 | 135 Million USD | -84.45% |
| 2007 Q3 | 934 Million USD | 2.52% |
| 2007 FY | 3.51 Billion USD | 11.19% |
| 2007 Q1 | 815 Million USD | -18.49% |
| 2007 Q2 | 911 Million USD | 11.78% |
| 2007 Q4 | 855 Million USD | -8.46% |
| 2006 Q3 | 904.9 Million USD | 18.3% |
| 2006 Q4 | 999.9 Million USD | 10.5% |
| 2006 Q2 | 764.9 Million USD | 55.59% |
| 2006 Q1 | 491.6 Million USD | 76.26% |
| 2006 FY | 3.16 Billion USD | 24.29% |
| 2005 Q1 | 746.1 Million USD | -8.36% |
| 2005 Q2 | 754.5 Million USD | 1.13% |
| 2005 Q3 | 764 Million USD | 1.26% |
| 2005 FY | 2.54 Billion USD | -9.06% |
| 2005 Q4 | 278.9 Million USD | -63.49% |
| 2004 Q3 | 657.8 Million USD | -3.48% |
| 2004 Q2 | 681.5 Million USD | 5.92% |
| 2004 FY | 2.79 Billion USD | 19.46% |
| 2004 Q1 | 643.4 Million USD | -7.53% |
| 2004 Q4 | 814.2 Million USD | 23.78% |
| 2003 Q1 | 546.4 Million USD | 29.36% |
| 2003 Q4 | 695.8 Million USD | 13.86% |
| 2003 Q3 | 611.1 Million USD | 25.23% |
| 2003 Q2 | 488 Million USD | -10.69% |
| 2003 FY | 2.34 Billion USD | 53.61% |
| 2002 Q3 | 443.1 Million USD | 102.88% |
| 2002 FY | 1.52 Billion USD | -1.63% |
| 2002 Q4 | 422.4 Million USD | -4.67% |
| 2002 Q2 | 218.4 Million USD | -50.4% |
| 2002 Q1 | 440.3 Million USD | 98.15% |
| 2001 Q3 | 444.7 Million USD | -4.32% |
| 2001 Q2 | 464.8 Million USD | 8.7% |
| 2001 Q1 | 427.6 Million USD | -10.38% |
| 2001 FY | 1.54 Billion USD | -4.89% |
| 2001 Q4 | 222.2 Million USD | -50.03% |
| 2000 Q3 | 392.6 Million USD | 3.1% |
| 2000 Q4 | 477.1 Million USD | 21.52% |
| 2000 FY | 1.62 Billion USD | 98.18% |
| 2000 Q1 | 368.8 Million USD | 52.71% |
| 2000 Q2 | 380.8 Million USD | 3.25% |
| 1999 FY | 822 Million USD | 17.09% |
| 1999 Q1 | 226.1 Million USD | -7.49% |
| 1999 Q2 | 217.4 Million USD | -3.85% |
| 1999 Q3 | 17 Million USD | -92.18% |
| 1999 Q4 | 241.5 Million USD | 1320.59% |
| 1998 FY | 702 Million USD | -13.25% |
| 1998 Q4 | 244.4 Million USD | 1551.35% |
| 1998 Q1 | 223.7 Million USD | 0.68% |
| 1998 Q2 | 219.1 Million USD | -2.06% |
| 1998 Q3 | 14.8 Million USD | -93.25% |
| 1997 Q4 | 222.2 Million USD | 13.08% |
| 1997 Q3 | 196.5 Million USD | 0.31% |
| 1997 Q2 | 195.9 Million USD | 0.72% |
| 1997 Q1 | 194.5 Million USD | 1.57% |
| 1997 FY | 809.2 Million USD | 21.07% |
| 1996 Q2 | 159.7 Million USD | 4.93% |
| 1996 Q4 | 191.5 Million USD | 15.08% |
| 1996 Q3 | 166.4 Million USD | 4.2% |
| 1996 Q1 | 152.2 Million USD | 15.3% |
| 1996 FY | 668.4 Million USD | 51.19% |
| 1995 Q1 | 97.9 Million USD | -1.71% |
| 1995 Q2 | 104.8 Million USD | 7.05% |
| 1995 Q4 | 132 Million USD | 22.91% |
| 1995 Q3 | 107.4 Million USD | 2.48% |
| 1995 FY | 442.1 Million USD | 27.48% |
| 1994 Q2 | 83.9 Million USD | 7.02% |
| 1994 Q1 | 78.4 Million USD | -8.73% |
| 1994 Q3 | 84.9 Million USD | 1.19% |
| 1994 Q4 | 99.6 Million USD | 17.31% |
| 1994 FY | 346.8 Million USD | 15.95% |
| 1993 Q4 | 85.9 Million USD | 21.33% |
| 1993 Q3 | 70.8 Million USD | -20.18% |
| 1993 Q1 | 68.6 Million USD | -3.79% |
| 1993 Q2 | 88.7 Million USD | 29.3% |
| 1993 FY | 299.1 Million USD | 23.14% |
| 1992 Q3 | 59.3 Million USD | 2.42% |
| 1992 Q2 | 57.9 Million USD | 6.63% |
| 1992 Q1 | 54.3 Million USD | -8.12% |
| 1992 Q4 | 71.3 Million USD | 20.24% |
| 1992 FY | 242.9 Million USD | 23.74% |
| 1991 Q4 | 59.1 Million USD | 17.96% |
| 1991 Q1 | 41.8 Million USD | -8.53% |
| 1991 Q2 | 42.7 Million USD | 2.15% |
| 1991 Q3 | 50.1 Million USD | 17.33% |
| 1991 FY | 196.3 Million USD | 22.76% |
| 1990 Q4 | 45.7 Million USD | 14.82% |
| 1990 FY | 159.9 Million USD | 6.39% |
| 1990 Q3 | 39.8 Million USD | 3.38% |
| 1990 Q2 | 38.5 Million USD | -78.75% |
| 1990 Q1 | 181.2 Million USD | 143.76% |
| 1989 Q3 | 175.8 Million USD | -2.98% |
| 1989 Q1 | 186.8 Million USD | 155.93% |
| 1989 FY | 150.3 Million USD | 14.65% |
| 1989 Q2 | 181.2 Million USD | -3.0% |
| 1989 Q4 | -414.1 Million USD | -335.55% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Abbott Laboratories | 6.47 Billion USD | 20.593% |
| Allurion Technologies Inc. | -78.07 Million USD | 6688.284% |
| Artivion, Inc. | 5.74 Million USD | -89485.51% |
| Avanos Medical, Inc. | 4.2 Million USD | -122376.19% |
| Butterfly Network, Inc. | -145.61 Million USD | 3632.724% |
| Butterfly Network, Inc. | -145.61 Million USD | 3632.724% |
| Bio-Rad Laboratories, Inc. | 383.79 Million USD | -1240.295% |
| Boston Scientific Corporation | 2.34 Billion USD | -119.548% |
| Perspective Therapeutics, Inc. | -15.18 Million USD | 33982.229% |
| CONMED Corporation | 130.78 Million USD | -3833.143% |
| Edwards Lifesciences Corporation | 1.53 Billion USD | -235.311% |
| Paragon 28, Inc. | -37.3 Million USD | 13887.558% |
| Glaukos Corporation | -128.7 Million USD | 4096.892% |
| Globus Medical, Inc. | 133.14 Million USD | -3763.544% |
| Inspire Medical Systems, Inc. | -40.27 Million USD | 12873.46% |
| Integer Holdings Corporation | 167.33 Million USD | -2974.165% |
| Nevro Corp. | -99.3 Million USD | 5279.845% |
| Owlet, Inc. | -28.63 Million USD | 18065.912% |
| Penumbra, Inc. | 73.55 Million USD | -6893.787% |
| Vicarious Surgical Inc. | -80.66 Million USD | 6476.912% |
| Smith & Nephew plc | 425 Million USD | -1110.353% |
| Sonendo, Inc. | -57.74 Million USD | 9008.439% |
| STERIS plc | 836.11 Million USD | -515.224% |
| Stryker Corporation | 3.88 Billion USD | -32.305% |
| Vapotherm, Inc. | -39.08 Million USD | 13262.743% |
| Zimmer Biomet Holdings, Inc. | 1.27 Billion USD | -302.598% |